Maria Di Bartolomeo

Fondazione IRCCS Istituto Nazionale dei Tumori ORCID: 0000-0002-7954-6609

1

h-index

1

Publications

1,262

Citations

Publications

1 shown

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

James Lynam , Niall C. Tebbutt , Mark Wong +97 more

2018 The Lancet 1262 citations

Frequent Co-Authors

James Lynam

Niall C. Tebbutt

Royal Marsden NHS Foundation Trust

Mark Wong

Andrew Strickland

Christos S. Karapetis

Florida Hospital Cancer Institute

David Goldstein

Princess Margaret Cancer Centre

Researcher Info

h-index: 1
Publications: 1
Citations: 1,262
Institution: Fondazione IRCCS Istituto Nazionale dei Tumori

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-7954-6609

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.